Verily App Adds AI Dry Eye Symptom Support Tool

Eye care practices may see more informed patients as the app provides guided symptom triage for 38 million diagnosed adults.

Updated on Oct. 15, 2026 in Healthcare

Isometric editorial illustration showing a polished glass lens and an iris aperture, symbolizing AI-guided optical diagnostic support.
Verily Health has integrated a new AI-guided dry eye symptom tool into its mobile platform, developed in partnership with Bausch + Lomb. AI Illustration. Upload story photo >

Live Poll

Do you trust AI-based mobile apps to provide accurate and reliable medical advice for your health?

Verily Health has partnered with Bausch + Lomb to integrate dry eye disease support into its Verily Me mobile application. The platform now features an AI-guided symptom tool designed to assist patients in preparing for eye care consultations.

Why it matters

By providing patients with clinically reviewed education and AI-driven symptom tracking, the partnership aims to improve clinical efficiency for eye care providers. Operators in healthcare should monitor how AI-guided pre-appointment triage tools impact patient preparation and practice workflows.

The application addresses a large market of 150 million U.S. adults with occasional or frequent dry eye symptoms, including 38 million who have a formal diagnosis of dry eye disease. These figures quantify the potential patient base for the new integrated support tool.

The players

Verily Health

An Alphabet-owned precision health technology company that develops data-driven platforms and AI-enabled health tools.

Bausch + Lomb

A global eye health company that produces pharmaceuticals, medical devices, and surgical instruments for ophthalmology.

The details

The Verily Me app leverages the Verily Pre health intelligence platform to offer structured symptom support. Users interact with Vi, an AI agent that prompts them with follow-up questions and reviews their health history before suggesting self-care steps. To ensure accuracy, the app utilizes clinically reviewed content combined with built-in safety checks for all user interactions.

Timeline

  1. October 15, 2026: Verily Health and Bausch + Lomb announced the partnership.

Market Landscape

This partnership leverages the Verily Pre health intelligence platform to expand digital health support into ophthalmology. It follows a broader industry trend of integrating clinical-grade AI agents into patient-facing apps to streamline pre-appointment communication.

Eye care practices should evaluate how patient use of AI-guided triage tools like Vi may influence the quality of intake data provided during visits. Consider if your practice needs to adjust internal documentation procedures as more patients arrive with AI-generated symptom summaries.

The takeaway

The move signals a shift toward using AI agents as a primary bridge between patient symptom tracking and clinical intake. Operators should monitor the accuracy of AI-facilitated history taking and determine whether to adopt similar digital pre-screening tools for their own patient cohorts.

Further reading

For more on industry shifts in digital diagnostics, visit Healthcare.

Source note: This article includes information reported by Healio.

Live Poll

Do you trust AI-based mobile apps to provide accurate and reliable medical advice for your health?